Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management
about
The emerging role of HE4 in the evaluation of epithelial ovarian and endometrial carcinomasTowards an evidence-based approach for diagnosis and management of adnexal masses: findings of the International Ovarian Tumour Analysis (IOTA) studiesUsefulness of diagnostic indices comprising clinical, sonographic, and biomarker data for discriminating benign from malignant ovarian masses.Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies.Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis.Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis.Distinguishing benign from malignant pelvic mass utilizing an algorithm with HE4, menopausal status, and ultrasound findings.Evaluation of human epididymis protein 4 (HE4) and Risk of Ovarian Malignancy Algorithm (ROMA) as diagnostic tools of type I and type II epithelial ovarian cancer in Japanese womenMajor clinical research advances in gynecologic cancer in 2011.Differential diagnosis of a pelvic mass: improved algorithms and novel biomarkersMR imaging of ovarian masses: classification and differential diagnosis.Biomarker testing for ovarian cancer: clinical utility of multiplex assaysClinical value of serum human epididymis protein 4 assay in the diagnosis of ovarian cancer: a meta-analysis.Preoperative HE4, CA125 and ROMA in the differential diagnosis of benign and malignant adnexal masses.Can ROMA algorithm stratify ovarian tumor patients better when being based on specific age ranges instead of the premenopausal and postmenopausal status?Diagnostic usefulness of the Risk of Ovarian Malignancy Algorithm using the electrochemiluminescence immunoassay for HE4 and the chemiluminescence microparticle immunoassay for CA125.HE4 Serum Levels in Patients with BRCA1 Gene Mutation Undergoing Prophylactic Surgery as well as in Other Benign and Malignant Gynecological Diseases.From bench to bedside: discovery of ovarian cancer biomarkers using high-throughput technologies in the past decade.The role of human epididymis protein 4 in the diagnosis of epithelial ovarian cancer.The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review.HE4-test of urine and body fluids for diagnosis of gynecologic cancer.An update on the role of PET/CT and PET/MRI in ovarian cancer.HE4 as a predictor of adjuvant chemotherapy resistance and survival in patients with epithelial ovarian cancer.The role of biomarkers in the management of epithelial ovarian cancer.Expression of miR-146a in patients with ovarian cancer and its clinical significance.Is serum human epididymis protein 4 ready for prime time?HE4, Ca125 and ROMA algorithm for differential diagnosis between benign gynaecological diseases and ovarian cancer.Does the Risk of Ovarian Malignancy Algorithm Provide Better Diagnostic Performance Than HE4 and CA125 in the Presurgical Differentiation of Adnexal Tumors in Polish Women?HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect.Integrated multiomic predictors for ovarian cancer survivalSerum Biomarker Based Algorithms in Diagnosis of Ovarian Cancer: A ReviewPrognostic values of HE4 expression in patients with cancer: a meta-analysisAssessment of Diagnostic Values among CA-125, RMI, HE4, and ROMA for Cancer Prediction in Women with Nonfunctional Ovarian Cysts
P2860
Q26992102-BA8F1C43-61BE-4288-8E11-237671CACDCEQ30414041-9BDF3BD3-4C75-4AA1-B845-6EF4B3B2D1F3Q30885682-57A4A226-0E0D-436C-81A1-7B9865F74E59Q34306120-53AB0760-FD71-4599-87F6-696149E1C06EQ34308808-68DAADB4-2131-4D0B-BEE1-750D7DF5D214Q34391119-0537F121-7F01-4719-BE83-8CA11D6C3F6BQ34996986-02675F35-9291-4D3A-8FA5-E47EFFC00E71Q35126762-A605FF41-9CD2-4B54-A0A2-FE4DF76D4B42Q35758722-B7687379-8B36-4099-A56F-AA98BD887613Q36076953-2C9D06E7-9513-4AC4-8443-3FF6A5AF5F48Q36510666-823FBF3F-31FA-4D35-BB40-FC46048131C4Q36897149-165534C1-5010-42E8-ABCB-4203FA79F9AFQ37053905-022428FC-18F8-4608-8F57-4F5B0381AD5FQ37111350-E07BE6D7-1B21-4E43-9B96-28808C2E8B14Q37188163-F750B27B-5131-4956-A925-FF33B17B04F5Q37406838-D83C3DC3-A7CA-45A8-9771-9FCD13A0FADBQ37611329-7256BF89-F5DF-4D51-9F6E-DEE00CB5D3E1Q38052927-04298B0D-C7C7-47A9-BC02-29F5FC591025Q38388103-99246BA6-ADB2-4D0F-AD07-AF12C289D969Q38653169-6F6A37AD-3E00-4A45-8146-2E593A427EFBQ38766453-D1BEC956-1A7E-4115-82E6-56224E6D6291Q39127714-1062FCE0-9559-4426-B1A7-344ABEB607D5Q39177243-7973CF80-92B6-418E-9717-86DC264FD1A9Q39281140-4F1E65E9-C0F0-493C-A423-F5E0A48512BDQ41618429-B2C16010-54AD-4428-92B9-03D2D03ED8B8Q50773867-3C0117BE-DF5D-4F62-93C9-70B0CA28940FQ51091632-9D203876-6BB7-49FD-B670-0E5D8E6A1322Q55280402-BBAA3F59-C3E9-464E-8909-ABEC7C77BF7CQ55430421-1194D3AC-CB3D-4BAB-A971-BC377F4895E6Q57177267-72E182C0-C52E-48FE-9D1B-F1108CAC307EQ57487046-BA2DA4A7-7658-492E-BDD7-6B3DA83ED3D5Q57816120-5C85592C-BAD2-4FC8-86A5-D906BE72C402Q58580738-E6DB7D33-F371-476D-8F91-75A97EC3AC80
P2860
Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Serum human epididymis protein ...... lial ovarian cancer management
@ast
Serum human epididymis protein ...... lial ovarian cancer management
@en
type
label
Serum human epididymis protein ...... lial ovarian cancer management
@ast
Serum human epididymis protein ...... lial ovarian cancer management
@en
prefLabel
Serum human epididymis protein ...... lial ovarian cancer management
@ast
Serum human epididymis protein ...... lial ovarian cancer management
@en
P2093
P2860
P50
P1476
Serum human epididymis protein ...... lial ovarian cancer management
@en
P2093
Alessandro D Santin
Claudia Specchia
Claudio Galli
Eliana Bignotti
Elisabetta Bandiera
Enrico Sartori
Germana Tognon
Giuseppina Ruggeri
Renata A Tassi
Sergio Pecorelli
P2860
P304
P356
10.1158/1055-9965.EPI-11-0635
P577
2011-10-25T00:00:00Z